http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047339-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc2a22a9271507062ad7e07974d3c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43c4553a3a440cfab3df83dbb5fd8cd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbe195501c55de4a7a3284e204a3c14d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
filingDate 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51478a26d9988bdb689b70ebfe2a425e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d534e00b04ea756814ecd48d7088343d
publicationDate 2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007047339-A3
titleOfInvention Methods of inhibiting poxvirus growth
abstract This disclosure ascribes new functions to derivatives of tetralin, anthraquinone, naphthylamine, tri-amino-pyrimidine, xanthen-3-one, and/or cinnamic acid (including, for example, NSC270718R, NSC1 17285R, NSC170008Y, NSC30671 IP, NSC1 19913X, NSC1 19915Z, NSC1 1991 IV, NSC1 1991OU, NSC128437O, NSC125908P, NSC9600Q, or NSC13778J, each obtained from the Structure Diversity Set, National Institutes of Health, National Cancer Institute, Developmental Therapeutics Program). These compounds are shown to be effective inhibitors of viral essential protein kinases (such as poxvirus B1 and/or F10 protein kinases). Exemplary chemical structures for viral protein kinase (VPK) inhibitors are provided, as are methods of using such compounds, for instance, to inhibit VPK activity and/or poxvirus growth, and/or for the treatment of poxvirus infection. Also provided are pharmaceutical compositions including disclosed VPK inhibitors.
priorityDate 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977061-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4073904-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4801593-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5521184-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57451334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230472477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226576031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11333049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456468049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415851892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394094

Total number of triples: 38.